Hutchison China Meditech News - 0J7G

Company Name	Stock Ticker Symbol	Market	Type
Hutchison China Meditech Ltd	0J7G	London	Ordinary Share

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	33.29	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
			33.29	33.29

more quote information »

Recent News

Date	Time	Source	Heading
1/11/2024	02:00	RNSNON	Hutchmed (China) Limited Sovleplenib NDA Granted Priority..
12/29/2023	03:30	UKREG	Hutchmed (China) Limited Total Voting Rights
12/29/2023	03:30	UKREG	Hutchmed (China) Limited Blocklisting Six Monthly Return
12/21/2023	05:00	UKREG	Hutchmed (China) Limited Overseas Regulatory Announcement
12/13/2023	02:00	RNSNON	Hutchmed (China) Limited Inclusion in National Reimbursement..
12/07/2023	05:04	UKREG	Hutchmed (China) Limited Overseas Regulatory Announcement
12/01/2023	02:00	RNSNON	Hutchmed (China) Limited Clinical Data to be Presented at..
11/30/2023	03:30	UKREG	Hutchmed (China) Limited Total Voting Rights
11/09/2023	02:00	UKREG	Hutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM)..
10/24/2023	04:30	UKREG	Hutchmed (China) Limited Vesting of awards under the LTIP
10/16/2023	04:30	RNSNON	Hutchmed (China) Limited Clinical Data to be Presented at..
9/29/2023	04:30	RNSNON	Hutchmed (China) Limited NDA Submission for Fruquintinib in..
9/29/2023	04:30	UKREG	Hutchmed (China) Limited Total Voting Rights
9/14/2023	04:30	UKREG	Hutchmed (China) Limited Director's Share Dealing
9/12/2023	04:30	RNSNON	Hutchmed (China) Limited Phase IIIb Savolitinib Results at..
9/12/2023	02:00	RNSNON	Hutchmed (China) Limited Patient Enrollment Completed for..
8/31/2023	04:30	UKREG	Hutchmed (China) Limited Total Voting Rights
8/29/2023	02:00	RNSNON	Hutchmed (China) Limited BTD in China for Savolitinib for..
8/21/2023	02:00	UKREG	Hutchmed (China) Limited Sovleplenib Phase 3 Study Meets..
8/07/2023	04:30	UKREG	Hutchmed (China) Limited Exercise of Share Options by a..
7/31/2023	07:00	UKREG	Hutchmed (China) Limited Interim Results and Business..
7/20/2023	02:00	RNSNON	Hutchmed (China) Limited Breakthrough Therapy Designation..
7/13/2023	04:30	UKREG	Hutchmed (China) Limited Changes to Board and Technical..
7/10/2023	02:00	RNSNON	Hutchmed (China) Limited Phase 1 Study of HMPL-415 Initiated
6/29/2023	04:30	UKREG	Hutchmed (China) Limited Blocklisting Six Monthly Return
6/26/2023	04:30	UKREG	Hutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year..
6/16/2023	02:00	UKREG	Hutchmed (China) Limited Phase III FRESCO-2 Results in The..
6/15/2023	10:39	UKREG	Hutchmed (China) Limited MAA of Fruquintinib Validated by..
6/09/2023	05:30	RNSNON	Hutchmed (China) Limited HUTCHMED Highlights Presentations..
6/06/2023	05:00	UKREG	Hutchmed (China) Limited LTIP and Share Option Scheme
5/31/2023	04:30	UKREG	Hutchmed (China) Limited Total Voting Rights
5/26/2023	02:00	RNSNON	Hutchmed (China) Limited HUTCHMED Highlights Presentations..
5/26/2023	02:00	UKREG	Hutchmed (China) Limited Fruquintinib NDA Granted Priority..
5/17/2023	04:30	UKREG	Hutchmed (China) Limited Standard form for notification of..
5/12/2023	08:15	UKREG	Hutchmed (China) Limited Annual General Meeting Poll Results
5/12/2023	04:30	UKREG	Hutchmed (China) Limited Board of Directors and Board..
5/10/2023	04:30	UKREG	Hutchmed (China) Limited Appointment of Independent NED